Role of calcium entry blockers in neurological diseases.
The current neurological indications for calcium entry blockers list a potential usefulness in tissue protection against the effects of cerebral anoxia and ischemia. Experimental data support these indications. Clinical data are preliminary so far and suggest designs for larger trials. A possible alternative strategy is the study of particular subgroups of patients such as the patients at excessive risk of stroke.
D000368:Aged; D002545:Brain Ischemia / Q000188:drug therapy; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000517:prevention & control*; D006801:Humans; D002534:Hypoxia, Brain / Q000188:drug therapy; D008875:Middle Aged
D002121:Calcium Channel Blockers